Evidence map›Paper›PMID 22026455›Full record

Trial reportScandinavian journal of infectious diseases2012

Vitamin D supplementation did not prevent influenza-like illness as diagnosed retrospectively by questionnaires in subjects participating in randomized clinical trials.

Rolf Jorde, Miles Witham, Wim Janssens, Lars Rolighed, Kyra Borchhardt, Ian H de Boer, Guri Grimnes, Moira S Hutchinson

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Scandinavian journal of infectious diseases, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 3 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 3 syntheses or guidelines pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Vitamin D3 supplementation and upper respiratory tract infections in a randomized, controlled trial.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2013
    Trial
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Vitamin D and Influenza-Prevention or Therapy?International journal of molecular sciences · 2018
    Review
  12. Review
  13. Vitamin D and airway infections: a European perspective.European journal of medical research · 2016
    Review
  14. Review
  15. Impact of vitamin D on infectious disease.The American journal of the medical sciences · 2015
    Review
  16. Article
  17. Article
  18. Vitamin D status and childhood health.Korean journal of pediatrics · 2013
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 6 countries.

Rolf JordeEndocrinology Research Group, Institute of Clinical Medicine, University of Tromsø, and Medical Clinic, University Hospital of North Norway, Tromsø, Norway. rolf.jorde@unn.no
Miles Witham
Wim Janssens
Lars Rolighed
Kyra Borchhardt
Ian H de Boer
Guri Grimnes
Moira S Hutchinson
University Hospital of North Norway · NOAarhus University Hospital · DKKU Leuven · BEMedical University of Vienna · ATUniversity of Dundee · GBUniversity of Washington · US

Funding

INSTITUTE FOR TRANSLATIONAL HEALTH SCIENCE (UL1): BPCAUL1RR025014 · NCRR · UNIVERSITY OF WASHINGTON · PI DISIS, MARY L. · 2007 to 2011
$51.5M
Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI Tomas Vaisar · 1986 to 2026
$41.4M
Institute for Translational Health Science (KL2)KL2RR025015 · NCRR · UNIVERSITY OF WASHINGTON · PI DISIS, MARY L. · 2007 to 2011
$9.3M
Chief Scientist Office CZH/4/470NCRR NIH HHS 5KL2RR025015NCRR NIH HHS KL2 RR025015NCRR NIH HHS UL1 RR025014NIDDK NIH HHS P30 DK017047
6 · The paper itself

Abstract

backgroundVitamin D deficiency has been associated with a number of diseases, including influenza. Whether or not this reflects a causal relationship is unknown. We therefore wanted to examine if supplementation with vitamin D would affect the incidence and severity of influenza-like disease.

methodsQuestionnaires on influenza were sent to subjects participating in ongoing placebo-controlled intervention studies with vitamin D supplementation, up until the end of April 2010.

resultsFive hundred and sixty-nine subjects from 10 different clinical trials were included in the study, of whom 289 were randomized to receive vitamin D (1111-6800 IU/day) and 280 to receive placebo. Influenza-like disease during the previous fall/winter was reported in 38 subjects in the vitamin D group and 42 in the placebo group (non-significant), of whom 25 and 26 subjects, respectively, fulfilled our clinical criteria for influenza. In these latter subjects, the duration of illness was significantly longer among those in the vitamin D group than among those in the placebo group (median 7 (range 2-60) days vs median 4 (range 2-18) days; p = 0.007). However, this difference was not statistically significant if all 38 (vitamin D) and 42 (placebo) subjects who reported symptoms were included.

conclusionOur results do not support the hypothesis that high doses of vitamin D supplementation will have a pronounced effect on influenza-like disease in populations not targeted for high influenza risk.

Indexed as

Data CollectionDietary SupplementsHumansInfluenza A Virus, H1N1 SubtypeInfluenza, HumanRetrospective StudiesSurveys and QuestionnairesVitamin DVitamin D

Identifiers

PMID22026455
PMCPMC3917712
OpenAlexW2033122683

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.